Approval of Tisotumab Vedotin in The Treatment of Cervical Cancer
home / news-network / approval-of-tisotumab-vedotin-in-the-treatment-of-cervical-cancer
Expert gynecologic oncologist Rebecca Arend, MD, MPH, addresses data from the 2021 ESMO meeting and the approval of tisotumab vedotin for patients with cervical cancer.